<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="inflammation, and pain but also reduces the risk of stroke," exact="heart attack," post="and some type of cancers [8,9,10]. The mechanism of"/>
 <result pre="[8,9,10]. The mechanism of analgesia occurred by aspirin involves the" exact="suppression" post="of prostaglandin synthesis by irreversible inhibition of the cyclooxygenases"/>
 <result pre="grifolin [30]. Grifolin shows anticancer activity in different types of" exact="cancer" post="by inducing apoptosis and arrest of cell growth [31,32,33,34,35]."/>
 <result pre="approach to fight against type-2 diabetes. 2.1.2. Anticancer Activity Today," exact="cancer" post="is a global concern, because of its leading position"/>
 <result pre="anticancer agent by inducing apoptosis and inhibiting proliferation of different" exact="cancer" post="cell lines, including human colorectal cancer cells (HT-29 and"/>
 <result pre="and inhibiting proliferation of different cancer cell lines, including human" exact="colorectal cancer" post="cells (HT-29 and T84), prostate cancer (PC-3), and breast"/>
 <result pre="inhibiting proliferation of different cancer cell lines, including human colorectal" exact="cancer" post="cells (HT-29 and T84), prostate cancer (PC-3), and breast"/>
 <result pre="cell lines, including human colorectal cancer cells (HT-29 and T84)," exact="prostate cancer" post="(PC-3), and breast cancer (MCF7) cells (IC50 values ranging"/>
 <result pre="lines, including human colorectal cancer cells (HT-29 and T84), prostate" exact="cancer" post="(PC-3), and breast cancer (MCF7) cells (IC50 values ranging"/>
 <result pre="colorectal cancer cells (HT-29 and T84), prostate cancer (PC-3), and" exact="breast cancer" post="(MCF7) cells (IC50 values ranging from 8 to 16"/>
 <result pre="cancer cells (HT-29 and T84), prostate cancer (PC-3), and breast" exact="cancer" post="(MCF7) cells (IC50 values ranging from 8 to 16"/>
 <result pre="(IC50 values ranging from 8 to 16 Î¼M in these" exact="cancer" post="cell lines) through targeting mitochondria. Treatment of HT-29 cells"/>
 <result pre="protein kinase (MAPK) pathway by reducing p38 activation [79], (iii)" exact="suppression" post="of inflammatory genes expression via SUMOylation-dependent pathway [80], and"/>
 <result pre="may have a beneficial effect for inflammatory disease, such as" exact="ulcerative colitis," post="via targeting PPARÎ³ [42]. 2.2. Ginkgolic Acids Some recent"/>
 <result pre="2.2.1. Anticancer Activity GA inhibited the proliferation of human Hep-2" exact="cancer" post="cells with the IC50 value of 20 ÂµM [82]"/>
 <result pre="of 20 ÂµM [82] and induced cell death in human" exact="hepatoblastoma" post="HepG2 cells via inducing apoptosis, autophagy, and mitochondrial dysfunction"/>
 <result pre="transcription 3) involves in the development of hematological malignancies in" exact="multiple myeloma." post="Phosphorylation of STAT3 stimulates different cancer related proteins, such"/>
 <result pre="hematological malignancies in multiple myeloma. Phosphorylation of STAT3 stimulates different" exact="cancer" post="related proteins, such as Bcl-xl, Bcl-2 (tumorigenesis), Cyclin D1"/>
 <result pre="activation [95,96]. Thus, recent studies have been focused on the" exact="suppression" post="of STAT3 activity for cancer treatment. Ginkgolic acid C"/>
 <result pre="have been focused on the suppression of STAT3 activity for" exact="cancer" post="treatment. Ginkgolic acid C (GAC) 17:1 suppressed STAT3 phosphorylation"/>
 <result pre="treatment. Ginkgolic acid C (GAC) 17:1 suppressed STAT3 phosphorylation in" exact="multiple myeloma" post="U266 cells and significantly reduced cell proliferation in both"/>
 <result pre="survivin, IAP-1, COX-2, cyclin D1, VEGF, MMP-9, and MMP-2, in" exact="multiple myeloma" post="cells [49]. In SW480 colon cancer cells, GA treatment"/>
 <result pre="MMP-9, and MMP-2, in multiple myeloma cells [49]. In SW480" exact="colon cancer" post="cells, GA treatment inhibited proliferation, migration, and invasion by"/>
 <result pre="and MMP-2, in multiple myeloma cells [49]. In SW480 colon" exact="cancer" post="cells, GA treatment inhibited proliferation, migration, and invasion by"/>
 <result pre="type 4 (CXCR4), and urinary-type plasminogen activator (uPA) [48]. In" exact="lung cancer" post="cells, GA treatment ameliorated migration and invasion by inhibition"/>
 <result pre="4 (CXCR4), and urinary-type plasminogen activator (uPA) [48]. In lung" exact="cancer" post="cells, GA treatment ameliorated migration and invasion by inhibition"/>
 <result pre="the PI3K/Akt/mTOR signaling pathway [46]. GA reduced the viability of" exact="pancreatic cancer" post="cells Panc-1 and BxPC-3. Both in vitro and in"/>
 <result pre="PI3K/Akt/mTOR signaling pathway [46]. GA reduced the viability of pancreatic" exact="cancer" post="cells Panc-1 and BxPC-3. Both in vitro and in"/>
 <result pre="results suggested that GA prevented the de novo lipogenesis of" exact="pancreatic cancer" post="cells by inducing the activation of AMPK signaling pathway"/>
 <result pre="suggested that GA prevented the de novo lipogenesis of pancreatic" exact="cancer" post="cells by inducing the activation of AMPK signaling pathway"/>
 <result pre="expression involved in lipogenesis [47]. In MCF-7 and MDA-MB 231" exact="breast cancer" post="cells, GA treatment showed antimigratory effects and inhibited the"/>
 <result pre="involved in lipogenesis [47]. In MCF-7 and MDA-MB 231 breast" exact="cancer" post="cells, GA treatment showed antimigratory effects and inhibited the"/>
 <result pre="(PAI-1), CXCR4, and MMP-9 [45]. GA inhibited the proliferation of" exact="renal cell carcinoma" post="(RCC) cell lines 786-O and A498 by inactivating the"/>
 <result pre="[83]. So, GA can be an efficient target for developing" exact="cancer" post="treatment. 2.2.2. Neuroprotective Activity The aberrant SUMOylation process has"/>
 <result pre="cytomegalovirus (HCMV), human immune deficiency virus (HIV), Ebola virus (EBOV)," exact="influenza" post="A virus (IAV), and Epstein Barr virus (EBV) and"/>
 <result pre="treatment reduced cell viability on GH3 cells, the rat anterior" exact="pituitary adenoma" post="cells, in a dose- and time-dependent manner (from 2.5"/>
 <result pre="reduced cell viability on GH3 cells, the rat anterior pituitary" exact="adenoma" post="cells, in a dose- and time-dependent manner (from 2.5"/>
 <result pre="G-protein coupled receptor 120 (GPR120) activity, grifolic acid reduced GH3" exact="adenoma" post="cell viability by blocking NADH production in mitochondria, thereby"/>
 <result pre="the same mechanism of grifolic acid in the case of" exact="osteosarcoma" post="cell death. Grifolic acid treatment reduced cell viability in"/>
 <result pre="cell viability in a time- and dose-dependent manner on four" exact="osteosarcoma" post="cell lines U-2 OS, MG-63, Saos-2, and 143B. Total"/>
 <result pre="model, intratumoral injection of grifolic acid increased necrosis of human" exact="osteosarcoma" post="xenograft in nude mice without any observable toxicity [30]."/>
 <result pre="THCA inhibited COX2 expression in a dose-dependent manner in three" exact="colon cancer" post="cell lines HCT116, HT29, and CaCO2. In addition, THCA"/>
 <result pre="inhibited COX2 expression in a dose-dependent manner in three colon" exact="cancer" post="cell lines HCT116, HT29, and CaCO2. In addition, THCA"/>
 <result pre="respectively [61]. CBDA reduced COX2 expression in triple-negative MDA-MB-231 human" exact="breast cancer" post="cell with a concentration of 5 ÂµM by abrogating"/>
 <result pre="[61]. CBDA reduced COX2 expression in triple-negative MDA-MB-231 human breast" exact="cancer" post="cell with a concentration of 5 ÂµM by abrogating"/>
 <result pre="(AP-I) and peroxisome proliferator-activated receptor PPARÎ²/Î´ [63]. CBDA inhibited human" exact="breast cancer" post="cell metastasis by suppressing COX2 and proto-oncogene c-Fos expression"/>
 <result pre="and peroxisome proliferator-activated receptor PPARÎ²/Î´ [63]. CBDA inhibited human breast" exact="cancer" post="cell metastasis by suppressing COX2 and proto-oncogene c-Fos expression"/>
 <result pre="expression and upregulating the expression of SHARP1(1.72-fold), a suppressor of" exact="breast cancer" post="metastasis [63,64,65,66]. 2.4.5. Antiemetic Effect and Anticonvulsant Effect 5-HT1A"/>
 <result pre="and upregulating the expression of SHARP1(1.72-fold), a suppressor of breast" exact="cancer" post="metastasis [63,64,65,66]. 2.4.5. Antiemetic Effect and Anticonvulsant Effect 5-HT1A"/>
 <result pre="antagonists: The Cache County StudyNeurology2000542066207110.1212/WNL.54.11.206610851364 9.ThunM.J.JacobsE.J.PatronoC.The role of aspirin in" exact="cancer" post="preventionNat. Rev. Clin. Oncol.2012925926710.1038/nrclinonc.2011.19922473097 10.ShirakawaK.WangL.ManN.MaksimoskaJ.SorumA.W.LimH.W.LeeI.S.ShimazuT.NewmanJ.C.SchrÃ¶derS.et al.Salicylate, diflunisal and their"/>
 <result pre="of I(kappa)B kinase-betaNature1998396778010.1038/239489817203 24.MinS.W.ChenX.TracyT.E.LiY.ZhouY.WangC.ShirakawaK.MinamiS.S.DefensorE.MokS.A.et al.Critical role of acetylation in tau-mediated" exact="neurodegeneration" post="and cognitive deficitsNat. Med.2015211154116210.1038/nm.395126390242 25.MitscherL.A.ParkY.H.AlShammaA.HudsonP.HaasT.Amorfrutin A and B, bibenzyl"/>
 <result pre="the Ginkgo Tree (Ginkgo biloba)J. Chromatogr. Sci.20003816917310.1093/chromsci/38.4.16910766484 30.ZhaoY.F.JiangF.LiangX.Y.WeiL.-L.ZhaoY.Y.MaQ.HuY.S.SuX.Grifolic acid causes" exact="osteosarcoma" post="cell death in vitro and in tumor-bearing miceBiomed. Pharmacother.20181031035104210.1016/j.biopha.2018.04.13229710661"/>
 <result pre="induces apoptosis via inhibition of PI3K/AKT signalling pathway in human" exact="osteosarcoma" post="cellsApoptosis2007121317132610.1007/s10495-007-0062-z17333316 33.LuoX.YangL.XiaoL.XiaX.DongX.ZhongJ.LiuY.LiN.ChenL.HongdeL.et al.Grifolin directly targets ERK1/2 to epigenetically suppress"/>
 <result pre="osteosarcoma cellsApoptosis2007121317132610.1007/s10495-007-0062-z17333316 33.LuoX.YangL.XiaoL.XiaX.DongX.ZhongJ.LiuY.LiN.ChenL.HongdeL.et al.Grifolin directly targets ERK1/2 to epigenetically suppress" exact="cancer" post="cell metastasisOncotarget20156427044271610.18632/oncotarget.567826516701 34.CheX.YanH.SunH.DongolS.WangY.LvQ.JiangJ.Grifolin induces autophagic cell death by inhibiting"/>
 <result pre="autophagic cell death by inhibiting the Akt/mTOR/S6K pathway in human" exact="ovarian cancer" post="cellsOncol. Rep.2016361041104710.3892/or.2016.484027277722 35.WuZ.LiY.Grifolin exhibits anti-cancer activity by inhibiting the"/>
 <result pre="cell death by inhibiting the Akt/mTOR/S6K pathway in human ovarian" exact="cancer" post="cellsOncol. Rep.2016361041104710.3892/or.2016.484027277722 35.WuZ.LiY.Grifolin exhibits anti-cancer activity by inhibiting the"/>
 <result pre="invasion of gastric tumor cellsOncotarget20178214542146010.18632/oncotarget.1525028206955 36.ZhaoY.F.ZhangL.YanA.ChenD.XieR.LiuY.LiangX.ZhaoY.WeiL.YuJ.et al.Grifolic acid induces GH3" exact="adenoma" post="cell death by inhibiting ATP production through a GPR120-independent"/>
 <result pre="Drug TreatmentMol. Cell. Proteom.2013121965197910.1074/mcp.M112.02503123579186 44.ZhuC.NaN.ShengH.FengB.WangH.ZhuP.ZhangW.ZhangM.DengZ.Ginkgolic acid inhibits the growth of" exact="renal cell carcinoma" post="cells via inactivation of the EGFR signaling pathwayExp. Ther."/>
 <result pre="EGFR signaling pathwayExp. Ther. Med.2020192949295610.3892/etm.2020.857032256780 45.HamdounS.EfferthT.Ginkgolic acids inhibit migration in" exact="breast cancer" post="cells by inhibition of NEMO sumoylation and NF-ÎºB activityOncotarget20178351033511510.18632/oncotarget.1662628402272"/>
 <result pre="signaling pathwayExp. Ther. Med.2020192949295610.3892/etm.2020.857032256780 45.HamdounS.EfferthT.Ginkgolic acids inhibit migration in breast" exact="cancer" post="cells by inhibition of NEMO sumoylation and NF-ÎºB activityOncotarget20178351033511510.18632/oncotarget.1662628402272"/>
 <result pre="InactivationJ. Cell. Physiol.201623234635410.1002/jcp.2542627177359 47.MaJ.DuanW.HanS.LeiJ.XuQ.ChenX.JiangZ.NanL.LiJ.ChenK.et al.Ginkgolic acid suppresses the development of" exact="pancreatic cancer" post="by inhibiting pathways driving lipogenesisOncotarget20156209932100310.18632/oncotarget.366325895130 48.QiaoL.ZhengJ.JinX.WeiG.WangG.SunX.LiX.Ginkgolic acid inhibits the"/>
 <result pre="Cell. Physiol.201623234635410.1002/jcp.2542627177359 47.MaJ.DuanW.HanS.LeiJ.XuQ.ChenX.JiangZ.NanL.LiJ.ChenK.et al.Ginkgolic acid suppresses the development of pancreatic" exact="cancer" post="by inhibiting pathways driving lipogenesisOncotarget20156209932100310.18632/oncotarget.366325895130 48.QiaoL.ZhengJ.JinX.WeiG.WangG.SunX.LiX.Ginkgolic acid inhibits the"/>
 <result pre="inhibiting pathways driving lipogenesisOncotarget20156209932100310.18632/oncotarget.366325895130 48.QiaoL.ZhengJ.JinX.WeiG.WangG.SunX.LiX.Ginkgolic acid inhibits the invasiveness of" exact="colon cancer" post="cells through AMPK activationOncol. Lett.2017145831583810.3892/ol.2017.696729113214 49.BaekS.H.LeeJ.H.KimC.KoJ.H.RyuS.H.LeeS.G.YangW.M.UmJ.Y.ChinnathambiA.AlharbiS.A.et al.Ginkgolic Acid C"/>
 <result pre="pathways driving lipogenesisOncotarget20156209932100310.18632/oncotarget.366325895130 48.QiaoL.ZhengJ.JinX.WeiG.WangG.SunX.LiX.Ginkgolic acid inhibits the invasiveness of colon" exact="cancer" post="cells through AMPK activationOncol. Lett.2017145831583810.3892/ol.2017.696729113214 49.BaekS.H.LeeJ.H.KimC.KoJ.H.RyuS.H.LeeS.G.YangW.M.UmJ.Y.ChinnathambiA.AlharbiS.A.et al.Ginkgolic Acid C"/>
 <result pre="Pharmacol.20131687910210.1111/j.1476-5381.2012.02027.x22594963 63.Hirao-SuzukiM.TakedaS.KogaT.TakiguchiM.TodaA.Cannabidiolic acid dampens the expression of cyclooxygenase-2 in MDA-MB-231" exact="breast cancer" post="cells: Possible implication of the peroxisome proliferator-activated receptor Î²/Î´"/>
 <result pre="63.Hirao-SuzukiM.TakedaS.KogaT.TakiguchiM.TodaA.Cannabidiolic acid dampens the expression of cyclooxygenase-2 in MDA-MB-231 breast" exact="cancer" post="cells: Possible implication of the peroxisome proliferator-activated receptor Î²/Î´"/>
 <result pre="Sci.20204522723610.2131/jts.45.22732238697 64.TakedaS.OkazakiH.IkedaE.AbeS.YoshiokaY.WatanabeK.AramakiH.Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human" exact="breast cancer" post="cellsJ. Toxicol. Sci.20143971171610.2131/jts.39.71125242400 65.TakedaS.OkajimaS.MiyoshiH.YoshidaK.OkamotoY.OkadaT.AmamotoT.WatanabeK.OmiecinskiC.J.AramakiH.Cannabidiolic acid, a major cannabinoid in"/>
 <result pre="64.TakedaS.OkazakiH.IkedaE.AbeS.YoshiokaY.WatanabeK.AramakiH.Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast" exact="cancer" post="cellsJ. Toxicol. Sci.20143971171610.2131/jts.39.71125242400 65.TakedaS.OkajimaS.MiyoshiH.YoshidaK.OkamotoY.OkadaT.AmamotoT.WatanabeK.OmiecinskiC.J.AramakiH.Cannabidiolic acid, a major cannabinoid in"/>
 <result pre="major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231" exact="breast cancer" post="cell migrationToxicol. Lett.201221431431910.1016/j.toxlet.2012.08.02922963825 66.SuzukiM.TakedaS.OkazakiH.WatanabeK.TakiguchiM.AramakiH.Cannabidiolic Acid-Mediated Interference with AP-1 Transcriptional"/>
 <result pre="cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast" exact="cancer" post="cell migrationToxicol. Lett.201221431431910.1016/j.toxlet.2012.08.02922963825 66.SuzukiM.TakedaS.OkazakiH.WatanabeK.TakiguchiM.AramakiH.Cannabidiolic Acid-Mediated Interference with AP-1 Transcriptional"/>
 <result pre="natural plant ginkgolic acids on the apoptosis of human Hep-2" exact="cancer" post="cellsSichuan Da Xue Xue Bao. Yi Xue Ban (J."/>
 <result pre="Biotechnol.20171711210.1186/s12896-016-0324-328056928 85.HongC.FirestoneG.L.BjeldanesL.F.Bcl-2 family-mediated apoptotic effects of 3,3â€²-diindolylmethane (DIM) in human" exact="breast cancer" post="cellsBiochem. Pharmacol.2002631085109710.1016/S0006-2952(02)00856-011931841 86.Wesche-SoldatoD.E.SwanR.Z.ChungC.S.AyalaA.The apoptotic pathway as a therapeutic target"/>
 <result pre="85.HongC.FirestoneG.L.BjeldanesL.F.Bcl-2 family-mediated apoptotic effects of 3,3â€²-diindolylmethane (DIM) in human breast" exact="cancer" post="cellsBiochem. Pharmacol.2002631085109710.1016/S0006-2952(02)00856-011931841 86.Wesche-SoldatoD.E.SwanR.Z.ChungC.S.AyalaA.The apoptotic pathway as a therapeutic target"/>
 <result pre="caspase activation, phosphatidylserine externalization, and PARP cleavage induced apoptosis in" exact="colorectal cancer" post="cells [28] Anti-inflammatory Lowering the expression of various inflammatory"/>
 <result pre="activation, phosphatidylserine externalization, and PARP cleavage induced apoptosis in colorectal" exact="cancer" post="cells [28] Anti-inflammatory Lowering the expression of various inflammatory"/>
 <result pre="acids G. biloba L. Anticancer Inhibition of the proliferation of" exact="renal cell carcinoma" post="(RCC) cell lines 786-O and A498 by inactivating epidermal"/>
 <result pre="of the activity of NF-ÎºB in MCF-7 and MDA-MB 231" exact="breast cancer" post="cells [45] Inhibition of the PI3K/Akt/mTOR signaling pathway of"/>
 <result pre="the activity of NF-ÎºB in MCF-7 and MDA-MB 231 breast" exact="cancer" post="cells [45] Inhibition of the PI3K/Akt/mTOR signaling pathway of"/>
 <result pre="cancer cells [45] Inhibition of the PI3K/Akt/mTOR signaling pathway of" exact="lung cancer" post="cells [46] Reduction of the cell viability and prevention"/>
 <result pre="cells [45] Inhibition of the PI3K/Akt/mTOR signaling pathway of lung" exact="cancer" post="cells [46] Reduction of the cell viability and prevention"/>
 <result pre="cell viability and prevention of the de novo lipogenesis of" exact="pancreatic cancer" post="cells [47] Reduction of proliferation, migration, and invasion of"/>
 <result pre="viability and prevention of the de novo lipogenesis of pancreatic" exact="cancer" post="cells [47] Reduction of proliferation, migration, and invasion of"/>
 <result pre="cells [47] Reduction of proliferation, migration, and invasion of SW480" exact="colon cancer" post="cells. Stimulation of AMPK activation and decreasing the expression"/>
 <result pre="[47] Reduction of proliferation, migration, and invasion of SW480 colon" exact="cancer" post="cells. Stimulation of AMPK activation and decreasing the expression"/>
 <result pre="Suppression of STAT3 phosphorylation and reduction of cell proliferation in" exact="multiple myeloma" post="cancer cells. Upregulation of the expression of PTEN and"/>
 <result pre="STAT3 phosphorylation and reduction of cell proliferation in multiple myeloma" exact="cancer" post="cells. Upregulation of the expression of PTEN and SHP-1"/>
 <result pre="combination of apoptosis, autophagy, and the mitochondrial pathway in human" exact="hepatoblastoma" post="HepG2 cells [51] Neuroprotective Enhancement of long-term potentiation (LTP)"/>
 <result pre="inhibiting MMP and ATP production on both GH3 cells and" exact="osteosarcoma" post="cell [30,36] Tetrahydro-cannabinolic acid (THCA) C. sativa Immunomodulatory Targeting"/>
 <result pre="expression, Reduction of prostaglandin production also inhibition MMP9 expression in" exact="colon cancer" post="cell [57,58] Neuroprotective Reduction of dopaminergic neurons degenerative effect"/>
 <result pre="Reduction of prostaglandin production also inhibition MMP9 expression in colon" exact="cancer" post="cell [57,58] Neuroprotective Reduction of dopaminergic neurons degenerative effect"/>
 <result pre="mice model [60] Antineoplastic Inhibition of cell proliferation in the" exact="breast cancer" post="cell and prostate carcinoma cell [61,62] Cannabidiolic acid (CBDA)"/>
 <result pre="model [60] Antineoplastic Inhibition of cell proliferation in the breast" exact="cancer" post="cell and prostate carcinoma cell [61,62] Cannabidiolic acid (CBDA)"/>
 <result pre="activator protein I (AP-I) and peroxisome proliferator-activated receptor PPARÎ²/Î´ in" exact="breast cancer" post="cell [63] Inhibition of human breast cancer cell metastasis"/>
 <result pre="protein I (AP-I) and peroxisome proliferator-activated receptor PPARÎ²/Î´ in breast" exact="cancer" post="cell [63] Inhibition of human breast cancer cell metastasis"/>
 <result pre="receptor PPARÎ²/Î´ in breast cancer cell [63] Inhibition of human" exact="breast cancer" post="cell metastasis by suppressing COX2 and proto-oncogene c-Fos expression"/>
 <result pre="PPARÎ²/Î´ in breast cancer cell [63] Inhibition of human breast" exact="cancer" post="cell metastasis by suppressing COX2 and proto-oncogene c-Fos expression"/>
</results>
